GAM Systematic’s Quest Diagnostics DGX Stock Holding History

GAM Systematic’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$3.1M	Buy	33,060 +7,147	+28%	+$759K	0.44%	36
2017 Q2	$2.88M	Buy	25,913 +4,186	+19%	+$443K	0.41%	44
2017 Q1	$2.13M	Buy	21,727 +4,200	+24%	+$400K	0.42%	44
2016 Q4	$1.61M	Sell	17,527 -3,768	-18%	-$325K	0.38%	47
2016 Q3	$1.8M	Buy	21,295 +6,236	+41%	+$524K	0.38%	42
2016 Q2	$1.23M	Buy	15,059 +4,184	+38%	+$319K	0.3%	91
2016 Q1	$777K	Sell	10,875 -690	-6%	-$46.3K	0.2%	193
2015 Q4	$823K	Sell	11,565 -12,523	-52%	-$842K	0.23%	163
2015 Q3	$1.48M	Sell	24,088 -41,596	-63%	-$2.91M	0.34%	58
2015 Q2	$4.76M	Sell	65,684 -9,489	-13%	-$701K	0.6%	31
2015 Q1	$5.78M	Buy	75,173 +26,216	+54%	+$1.88M	0.8%	8
2014 Q4	$3.28M	Buy	+48,957	New	+$3.09M	0.67%	15

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAM Systematic's DGX Position: Q3 2017 in Review

GAM Systematic increased its Quest Diagnostics (DGX) stake by 28% in Q3 2017, buying an estimated $759K and bringing the position to 33,060 shares worth $3.1M. The position accounts for 0.44% of the portfolio, ranked #36.

GAM Systematic first reported a position in DGX in Q4 2014 and has held it in 12 quarters since. The position peaked at $5.78M in Q1 2015. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

GAM Systematic held 33,060 shares of Quest Diagnostics worth $3.1M as of Q3 2017.
GAM Systematic bought 7,147 Quest Diagnostics shares in Q3 2017, an estimated $759K.
Quest Diagnostics made up 0.44% of GAM Systematic's portfolio in Q3 2017, its #36 holding.
GAM Systematic first reported a position in Quest Diagnostics in Q4 2014 and has held it in 12 quarters since.
GAM Systematic's Quest Diagnostics position peaked at $5.78M in Q1 2015.
616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.